94 related articles for article (PubMed ID: 15518771)
1. A survey on the prevalence and management of hepatitis B after renal transplantation in Asian-Pacific countries.
Chan TM; Chapman J; Lee CJ; Morad Z; Ona ET; Park K; Pingle A; Rizvi SA; Shaheen FA; Sumethkul V; Tang XD; Watarai Y
Transplant Proc; 2004 Sep; 36(7):2126-7. PubMed ID: 15518771
[TBL] [Abstract][Full Text] [Related]
2. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
[TBL] [Abstract][Full Text] [Related]
3. Changes in serological markers of hepatitis B virus after renal transplantation.
Urbini Dos Santos C; Sevá-Pereira T; Alves-Filho G; Lorena SL; Soares EC; Mazzali M
Transplant Proc; 2008 Apr; 40(3):749-51. PubMed ID: 18455006
[TBL] [Abstract][Full Text] [Related]
4. Antiviral therapy for hepatitis B after kidney transplantation.
Chan TM
Transplant Proc; 2004 Sep; 36(7):2124-5. PubMed ID: 15518770
[TBL] [Abstract][Full Text] [Related]
5. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B-positive donors in renal transplantation: increasing the deceased donor pool.
Pilmore HL; Gane EJ
Transplantation; 2012 Aug; 94(3):205-10. PubMed ID: 22430067
[TBL] [Abstract][Full Text] [Related]
7. Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplantation in hepatitis B surface antigen-positive patients: A retrospective case series.
Huang YW; Liu CJ; Lai MY; Lee PH; Tsai MK; Wang SS; Lai MK; Kao JH
Clin Ther; 2006 Sep; 28(9):1327-34. PubMed ID: 17062306
[TBL] [Abstract][Full Text] [Related]
8. Occult hepatitis B in renal transplant patients.
Peres AA; Dias EA; Chesky M; Alvares-da-Silva MR; Jobim LF; Gonçalves LF; Manfro RC
Transpl Infect Dis; 2005 Jun; 7(2):51-6. PubMed ID: 16150090
[TBL] [Abstract][Full Text] [Related]
9. Reactivation of hepatitis and lamivudine therapy in 11 HBsAg-positive renal allograft recipients: a single centre experience.
Murakami R; Amada N; Sato T; Orii T; Kikuchi H; Haga I; Ohashi Y; Okazaki H
Clin Transplant; 2006; 20(3):351-8. PubMed ID: 16824154
[TBL] [Abstract][Full Text] [Related]
10. The incidence and clinical outcome of YMDD mutants in hepatitis B surface antigen-positive renal allograft recipients after prolonged lamivudine therapy.
Gwak GY; Huh W; Lee DH; Choi MS; Lee JH; Koh KC; Kim SJ; Joh JW; Oh HY
Transplant Proc; 2007 Dec; 39(10):3121-6. PubMed ID: 18089336
[TBL] [Abstract][Full Text] [Related]
11. Impact of hepatitis B and C virus infections on kidney transplantation: a single center experience.
Santos L; Alves R; Macario F; Parada B; Campos M; Mota A
Transplant Proc; 2009 Apr; 41(3):880-2. PubMed ID: 19376378
[TBL] [Abstract][Full Text] [Related]
12. HBV reactivation after kidney transplantation.
Berger A; Preiser W; Kachel HG; Stürmer M; Doerr HW
J Clin Virol; 2005 Feb; 32(2):162-5. PubMed ID: 15653420
[TBL] [Abstract][Full Text] [Related]
13. Risk of transmission of hepatitis B virus from anti-HBC positive cadaveric organ donors: a collaborative study.
De Feo TM; Poli F; Mozzi F; Moretti MP; Scalamogna M;
Transplant Proc; 2005 Mar; 37(2):1238-9. PubMed ID: 15848681
[TBL] [Abstract][Full Text] [Related]
14. The effect of HBsAg-positivity of kidney donors on long-term patient and graft outcome.
Berber I; Aydin C; Yigit B; Turkmen F; Titiz IM; Altaca G
Transplant Proc; 2005 Dec; 37(10):4173-5. PubMed ID: 16387070
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
16. Ten-year follow-up of kidney transplantation from hepatitis B surface antigen-positive donors.
Sumethkul V; Ingsathit A; Jirasiritham S
Transplant Proc; 2009; 41(1):213-5. PubMed ID: 19249516
[TBL] [Abstract][Full Text] [Related]
17. [Change in the serologic markers of hepatitis B after allogenic hematopoietic stem-cell transplantation].
Woo SY; Cho SH; Lee SM; Koh MB; Noh CH; Kim CW; Choi JY; Yang JM; Han JY; Lee YS
Korean J Hepatol; 2009 Jun; 15(2):131-9. PubMed ID: 19581765
[TBL] [Abstract][Full Text] [Related]
18. Relationship of hepatitis B or C virus prevalences, risk factors, and outcomes in renal transplant recipients: analysis of German data.
Kliem V; Burg M; Haller H; Suwelack B; Abendroth D; Fritsche L; Fornara P; Pietruck F; Frei U; Donauer J; Lison AE; Michel U
Transplant Proc; 2008 May; 40(4):909-14. PubMed ID: 18555076
[TBL] [Abstract][Full Text] [Related]
19. Does hepatitis C virus affect the reactivation of hepatitis B virus following renal transplantation?
Yen TH; Huang CC; Lin HH; Huang JY; Tian YC; Yang CW; Wu MS; Fang JT; Yu CC; Chiang YJ; Chu SH
Nephrol Dial Transplant; 2006 Apr; 21(4):1046-52. PubMed ID: 16390851
[TBL] [Abstract][Full Text] [Related]
20. Use of anti-HBc positive allografts in adult liver transplantation: toward a safer way to expand the donor pool.
Donataccio D; Roggen F; De Reyck C; Verbaandert C; Bodeus M; Lerut J
Transpl Int; 2006 Jan; 19(1):38-43. PubMed ID: 16359375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
